Regeneron Pharmaceuticals
IRS: 133444607REGN
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation.
Founded
1988 (33 years)
CEO
Leonard S. Schleifer
Revenue
9 billion (2020)